Background Recent studies in children and adults indicate that the prevalence of atopy and allergic disorders is lower in previously socialist countries in Eastern Europe compared with countries with a market economy while revealed risk factors are similar.
Objectives To estimate the prevalence of atopy among adults in Tartu, Estonia and to compare the prevalence of risk factors for atopy and allergic respiratory diseases in Estonia and Sweden.
Methods As a part of cross-sectional study-European Community Respiratory Health Survey-random samples of 20-44 year olds (n=351 in Tartu and n=470 in Uppsala) and persons of the same age with asthma like symptoms or on current asthma medication according to a postal questionnaire (n=95 in Tartu and n=201 in Uppsala) were interviewed and circulating IgE antibodies were measured.
Results The prevalence of atopy was 19% in Tartu and 32% in Uppsala (P<0.001).
The prevalence of sensitization to pollen was twice lower (11.5 vs 23.2 ; P<0.001) and the prevalence of pollen associated asthma symptoms was four times lower (1.7 vs 6.8 ; P<0.001) in Tartu than in Uppsala while sensitization to pollen was an equally large risk factor for asthma in both centres.
Age was inversely related to cat and pollen associated symptoms of rhinoconjunctivitis in Uppsala (OR 0.6 and 0.7, respectively, P<0.05) but not in Tartu.
Conclusions The prevalence of atopy was lower in Tartu, Estonia than in Uppsala Sweden. (...)
Mots-clés Pascal : Asthme, Allergie, Rhinite, Conjonctivite, Prévalence, Facteur risque, Epidémiologie, Etude comparative, Suède, Europe, Estonie, Europe Est, Adulte, Homme, Etude transversale, Appareil respiratoire pathologie, Bronchopneumopathie obstructive, Immunopathologie, ORL pathologie, Nez pathologie, Oeil pathologie, Conjonctive pathologie
Mots-clés Pascal anglais : Asthma, Allergy, Rhinitis, Conjunctivitis, Prevalence, Risk factor, Epidemiology, Comparative study, Sweden, Europe, Estonia, Eastern Europe, Adult, Human, Cross sectional study, Respiratory disease, Obstructive pulmonary disease, Immunopathology, ENT disease, Nose disease, Eye disease, Conjunctiva disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0427740
Code Inist : 002B06C01. Création : 25/01/1999.